Urinary dysfunction in early de novo patients with Parkinson's disease

Mov Disord. 2017 Jun;32(6):939-940. doi: 10.1002/mds.26967. Epub 2017 Mar 3.

Authors

Gennaro Pagano^{1

2}, Flavia Niccolini^{1

2}, Tayyabah Yousaf^{1

2}, Heather Wilson^{1

2}, Sotirios Polychronis^{1

2}, Kallol Ray Chaudhuri², Marios Politis^{1

2}

Affiliations

¹ Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK.
² National Parkinson Foundation International Centre of Excellence, Department of Basic & Clinical Neuroscience, King's College London and Kings College Hospital, London, UK.

PMID: 28256013
DOI: 10.1002/mds.26967

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Fluorodeoxyglucose F18 / pharmacokinetics
Humans
Kidney Diseases / cerebrospinal fluid
Kidney Diseases / diagnostic imaging
Kidney Diseases / epidemiology
Kidney Diseases / etiology*
Parkinson Disease / cerebrospinal fluid
Parkinson Disease / complications*
Parkinson Disease / diagnostic imaging
Parkinson Disease / epidemiology
Tropanes / pharmacokinetics
alpha-Synuclein / cerebrospinal fluid

Substances

Tropanes
alpha-Synuclein
Fluorodeoxyglucose F18
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane